期刊
NATURE REVIEWS CANCER
卷 9, 期 12, 页码 874-885出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2761
关键词
-
类别
资金
- NCI NIH HHS [CA97098, R01 CA097098, CA42802, P50 CA100707-010003, CA100707, P50 CA100707, R01 CA042802-13, R01 CA097098-01, R01 CA042802] Funding Source: Medline
Epithelia are protected from adverse conditions by a mucous barrier. The secreted and transmembrane mucins that constitute the mucous barrier are largely unrecognized as effectors of carcinogenesis. However, both types of mucins are intimately involved in inflammation and cancer. Moreover, diverse human malignancies overexpress transmembrane mucins to exploit their role in signalling cell growth and survival. Mucins have thus been identified as markers of adverse prognosis and as attractive therapeutic targets. Notably, the findings that certain transmembrane mucins induce transformation and promote tumour progression have provided the experimental basis for demonstrating that inhibitors of their function are effective as anti-tumour agents in preclinical models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据